Overview

Bioequivalence of Two Commercial Amoxicillin Suspensions

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The aim of the present study was to compare the pharmacokinetic profiles and to evaluate the bioequivalence of two commercial amoxicillin-suspension formulations in healthy Brazilian volunteers.
Phase:
Phase 4
Details
Lead Sponsor:
University of Campinas, Brazil
Collaborator:
Stiefel, a GSK Company
Treatments:
Amoxicillin